Loading clinical trials...
Loading clinical trials...
A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL®
Conditions
Interventions
NTX/BUP
NTX/PBO-B
+1 more
Locations
20
United States
North Country Clinical Research
Oceanside, California, United States
NRC Research Institute
Orange, California, United States
Atlantic Shores Hospital
Lauderhill, Florida, United States
TRY Research
Maitland, Florida, United States
Research Centers of America
Oakland Park, Florida, United States
CNS Healthcare
Orlando, Florida, United States
Start Date
August 1, 2015
Primary Completion Date
October 27, 2016
Completion Date
January 9, 2017
Last Updated
March 6, 2019
NCT06651177
NCT06843213
NCT05995886
NCT07044466
NCT07350148
NCT06585709
Lead Sponsor
Alkermes, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions